92 related articles for article (PubMed ID: 24050763)
1. Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms' tumor? A case report and literature review.
Provenzi M; Saettini F; Conter V; Chinaglia D; Vai P; Bruno A; Cavalleri L; Foglia C; Giraldi E; Collini P; Spreafico F
Pediatr Hematol Oncol; 2013 Oct; 30(7):633-9. PubMed ID: 24050763
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry.
Begent J; Sebire NJ; Levitt G; Brock P; Jones KP; Ell P; Gordon I; Anderson J
Eur J Cancer; 2011 Feb; 47(3):389-96. PubMed ID: 21074411
[TBL] [Abstract][Full Text] [Related]
3. FDG positron emission tomography/computed tomography studies of Wilms' tumor.
Moinul Hossain AK; Shulkin BL; Gelfand MJ; Bashir H; Daw NC; Sharp SE; Nadel HR; Dome JS
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1300-8. PubMed ID: 20204356
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
[TBL] [Abstract][Full Text] [Related]
5. Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.
Misch D; Steffen IG; Schönberger S; Voelker T; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H; Denecke T
Eur J Nucl Med Mol Imaging; 2008 Sep; 35(9):1642-50. PubMed ID: 18509634
[TBL] [Abstract][Full Text] [Related]
6. Local staging of Wilms' tumor--computerized tomography correlation with histological findings.
Gow KW; Roberts IF; Jamieson DH; Bray H; Magee JF; Murphy JJ
J Pediatr Surg; 2000 May; 35(5):677-9. PubMed ID: 10813321
[TBL] [Abstract][Full Text] [Related]
7. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
[TBL] [Abstract][Full Text] [Related]
8. Potential role of PET-CT in chemotherapy efficacy assessment and recurrence diagnosis in a patient with a Wilms' tumour.
Piwkowski P; Kołodziejczyk A; Macioszek A; Połczyńska K; Zebrowski J
Nucl Med Rev Cent East Eur; 2011; 14(1):33-5. PubMed ID: 21751170
[TBL] [Abstract][Full Text] [Related]
9. The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia.
Banwait R; O'Regan K; Campigotto F; Harris B; Yarar D; Bagshaw M; Leleu X; Leduc R; Ramaiya N; Weller E; Ghobrial IM
Am J Hematol; 2011 Jul; 86(7):567-72. PubMed ID: 21681781
[TBL] [Abstract][Full Text] [Related]
10. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
11. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.
Kitagawa Y; Sadato N; Azuma H; Ogasawara T; Yoshida M; Ishii Y; Yonekura Y
J Nucl Med; 1999 Jul; 40(7):1132-7. PubMed ID: 10405132
[TBL] [Abstract][Full Text] [Related]
12. 18F-fluorodeoxyglucose-positron emission tomography in the characterization of suspected rhabdoid renal tumor recurrence: a case report.
Pirro V; Skanjeti A; Pelosi E
J Pediatr Hematol Oncol; 2007 Jan; 29(1):69-71. PubMed ID: 17230072
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of (18)F-fluorodeoxyglucose PET for radiosurgery planning and response monitoring in patients with recurrent spinal metastasis.
Gwak HS; Youn SM; Chang U; Lee DH; Cheon GJ; Rhee CH; Kim K; Kim HJ
Minim Invasive Neurosurg; 2006 Jun; 49(3):127-34. PubMed ID: 16921451
[TBL] [Abstract][Full Text] [Related]
15. Role of FDG-PET in the assessment of survival prognosis in melanoma.
Pleiss C; Risse JH; Biersack HJ; Bender H
Cancer Biother Radiopharm; 2007 Dec; 22(6):740-7. PubMed ID: 18158764
[TBL] [Abstract][Full Text] [Related]
16. The value of surgery in directing therapy for patients with Wilms' tumor with pulmonary disease. A report from the National Wilms' Tumor Study Group (National Wilms' Tumor Study 5).
Ehrlich PF; Hamilton TE; Grundy P; Ritchey M; Haase G; Shamberger RC;
J Pediatr Surg; 2006 Jan; 41(1):162-7; discussion 162-7. PubMed ID: 16410127
[TBL] [Abstract][Full Text] [Related]
17. PET FDG studies of Wilms tumors.
Shulkin BL; Chang E; Strouse PJ; Bloom DA; Hutchinson RJ
J Pediatr Hematol Oncol; 1997; 19(4):334-8. PubMed ID: 9256833
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
Guay C; Lépine M; Verreault J; Bénard F
J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
[TBL] [Abstract][Full Text] [Related]
19. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
